Sign in
CompletedNo phase

Clinical Evaluation of the i-STAT TBI Test

Key facts

Who runs it
Abbott Point of Care
Where
Austin, Baltimore, Boston, Carmel, Cincinnati, Dallas, Denver, Englewood, Houston, Indianapolis, Lexington, Miami, Milwauke, Philadelphia, Pittsburgh, Richmond, Rochester, Salt Lake City, San Francisco, and Seattle, United StatesSee the 21 sites
Trial code
Status
Completed
People taking part
1,106 people enrolled
Started
31 Jul 2020
Ended
29 Nov 2023
Type of study
Observational
Treatments tested
  • Blood draw
  • Outcome assessments
Record updated
29 October 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 14 criteriaShow less

Other criteria

  • Acute Blood Biomarker Branch Subject Inclusion Criteria:
  • 18 years of age or older
  • Subject or Legally Authorized Representative (LAR) provided informed consent for the Acute Blood Biomarker Branch (waiver of consent may be acceptable, per IRB)
  • Subject presented to a health care facility or emergency department with a suspected TBI resulting from an insult to the head by an external force within 12 hours of the injury
  • Subject has a CT scan of the head with all sequences (bone and soft tissue) ordered as part of standard of care at the enrolling facility or are transferred to the enrolling facility with a head CT scan sent from the originating facility
  • As a result of this head injury, the subject has sustained a traumatically induced physiological disruption of brain function, as manifested by at least one of the following; Any period of loss of consciousness; Any loss of memory for events immediately before or after the injury; Any alteration of mental state at the time of the injury; Focal neurological deficits that may or may not be transient; Acute Blood Biomarker Branch Subject Exclusion Criteria
  • Previous enrollment in this study
  • Current (on-going) enrollment in a therapeutic or interventional clinical trial (drug or device)
  • Primary diagnosis at the enrolling facility of ischemic or hemorrhagic stroke
  • Time of injury is unknown and cannot be estimated
  • Presented with penetrating head trauma or spinal cord injury (American Spinal Injury Association [ASIA] score of C or worse) at the enrolling facility
  • Standard of care head CT scan procedures not completed prior to Emergency Department (ED) discharge
  • Prisoners or patients in custody
  • Patients on psychiatric hold

Where in United States

  • University of Texas AustinAustin, United States
  • University of Maryland Medical CenterBaltimore, United States
  • Massachusetts General HospitalBoston, United States
  • Rehabilitation Hospital of IndianaCarmel, United States
  • University of CincinnatiCincinnati, United States
  • University of Texas, South WesternDallas, United States
  • Denver Health and Hospital AuthorityDenver, United States
  • Craig HospitalEnglewood, United States
  • Baylor College of MedicineHouston, United States
  • University of Texas Health Sciences Center of HoustonHouston, United States
  • Indiana University School of MedicineIndianapolis, United States
  • University of KentuckyLexington, United States
  • University of MiamiMiami, United States
  • Medical College of WisconsinMilwauke, United States
  • Penn Presbyterian Medical CenterPhiladelphia, United States
  • University of Pittsburgh Medical Center, Presbyterian HospitalPittsburgh, United States
  • Virginia Commonwealth UniversityRichmond, United States
  • University of Rochester Medical CenterRochester, United States
  • University of UtahSalt Lake City, United States
  • University of California San FranciscoSan Francisco, United States
  • University of WashingtonSeattle, United States

About the trial

What the trial wants to find out

The goal of this study is to evaluate the i-STAT TBI test to assist determining the need for a computed tomography (CT) scan in patients with suspected mild traumatic brain injury (TBI).

Read full original descriptionShow less

Patients will be asked to provide a blood sample.

The group in the trial

  • Acute Blood Biomarker Branch

    Blood drawn within 12 hours or 12-24 hours following injury for i-STAT TBI Testing and in-person baseline outcome assessments.

    Treatment: Blood draw and Outcome assessments

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
29 October 2026